Tag: Office of Policy Planning

Displaying 1 - 20 of 328 results.

Pages

The Federal Trade Commission staff submitted a comment to the Texas Health and Human Services Commission that opposes issuing certificates of public advantage (COPAs) to Hendrick Health System and Shannon Health System.
The Federal Trade Commission staff has submitted a comment to the Texas Attorney General regarding a request from the Texas Medical Board for an opinion on the statutory basis for the supervision of certified registered nurse anesthetists (CRNAs).
The Federal Trade Commission (“FTC”) and the Department of Justice (“DOJ” or “Department”) issued today new Vertical Merger Guidelines that outline how the federal antitrust agencies evaluate the likely competitive impact of vertical mergers and whether those mergers comply with U.S. antitrust law.
The staffs of the Federal Trade Commission’s Office of Policy Planning, Bureau of Economics, Bureau of Competition, and Office of the General Counsel have submitted a comment to the Centers for Medicare & Medicaid Services, or CMS, on its Interim Final Rule with Comment Period, or IFC. The IFC...
Federal Trade Commission Chairman Joe Simons released a summary of the agency’s 2019 Annual Highlights today, calling attention to the Commission’s ongoing efforts to protect consumers and promote a competitive marketplace.
The staff of Federal Trade Commission’s Office of Policy Planning, Bureau of Economics, and Bureau of Competition, together with the staff of the Antitrust Division of the Department of Justice, have submitted a letter to California State Assembly Member Jim Wood raising concerns that California...
Comment by FTC and DOJ staff in response to invitation from California Assembly Member Jim Wood concerning the likely competitive effects of A.B.1541, a proposal to further restrict contracting between beer manufacturers and beer wholesalers.
Due to the developing COVID-19 coronavirus pandemic, and consistent with guidance from the Office of Personnel Management, the Federal Trade Commission has canceled its planned March 18, 2020 workshop on the draft Vertical Merger Guidelines. The FTC workshop was to be the second of a two-part...
The Federal Trade Commission staff has submitted a statement in support of certain changes made by the Department of Health & Human Services’ Office of the National Coordinator for Health Information Technology (ONC) in ONC’s 21st Century Cures Act: Interoperability, Information Blocking Final...
The workshop will be the first in a two-part series hosted together with the Department of Justice. The two workshops will allow for a dynamic discussion about the proposed guidelines to complement the written public comments about the proposed guidelines that were submitted to the...
The Federal Trade Commission in collaboration with the Food and Drug Administration held a public workshop, "FDA/FTC Workshop on a Competitive Marketplace for Biosimilars." The purpose of the public workshop was to discuss FDA and FTC’s collaborative efforts to support appropriate...
On March 9, 2020, the Federal Trade Commission and the Food and Drug Administration will co-sponsor a public workshop on promoting competition in biologics markets. The workshop will be held at the FDA’s White Oak Campus in Silver Spring, Maryland and will also be webcast.
Note: The FTC will host a conference call for media with FTC Chairman Joe Simons:Date: Feb. 11, 2020Time: 1 p.m. ETCall-in: 877-226-8216, confirmation number 4193234Call-in lines, which are for media only, will open 15 minutes prior to the start of the call.

Pages